Status:
TERMINATED
Proton Beam Radiation Therapy for Intraocular and Periocular Retinoblastoma
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Retinoblastoma
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this trial is to evaluate proton beam radiation therapy as an alternative to external photon beam irradiation in children with retinoblastoma as a means of local tumor control and ocula...
Detailed Description
External photon beam radiation therapy (which is current standard of care) has been used in the treatment of retinoblastoma. It is a form of radiation therapy in which the radiation is delivered by a ...
Eligibility Criteria
Inclusion
- Active or recurrent retinoblastoma patient eligible for treatment of external beam radiation therapy.
- A parent or guardian who can provide informed consent to a minor or child participant.
- No concurrent infection.
- No contraindication for repeated general anesthesia/sedation.
Exclusion
- Inability to return for multiple examinations under anesthesia.
- Medical contraindication for exams under anesthesia/sedation.
- Unreliable follow-up.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2014
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00432445
Start Date
January 1 2007
End Date
February 1 2014
Last Update
February 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030